Products and Solutions
Resource Center
News and Events
Partnerships
Careers
About Us
Cegedim’s UK GM, David Round, and NHS Alliance CEO, Mike Sobanja, examine the implications of the Health & Social Care Bill for the pharmaceutical industry in the next 12 months.
April 2012 | Press coverage
March 2012 – In this article about improving regulatory compliance in the wake of global legislation around anti-corruption, Pf quotes Bill Buzzeo, VP of Global Compliance Solutions at Cegedim Relationship Management.
February 2012 – David Round, GM Cegedim Relationship Management UK, is quoted in this article discussing how a combination of new business thinking and new technology can turn customer data into powerful insight.
February 2012 | Press coverage
February 2012 – Issues around the financial interests of physicians and academic medical centers in the US, as regards their relationship with pharma, have crossed the Atlantic from the US and are now breaking through the clouds in Europe.
February 2012 – Paul Kandle, VP & GM of OPUS Health, a division of Cegedim Relationship Management, offers commentary on this aspect of customer relationship management.
February 2012 – Survey results show that pharma, biotech and medical device organizations in Europe are committed to achieving operational compliance, but find incomplete data and internal system inefficiencies to be their greatest challenges.
February 2012 – With mobile technologies, life sciences commercial teams have an unprecedented opportunity to be innovative, to get ahead of the competition, and to achieve real benefits through improved customer relationships and transformed representative productivity.
January/February 2012 – David Round, GM Cegedim Relationship Management UK, explains why the arrival of technologies such as Customer Relationship Management (CRM) on the iPad has combined with a technically savvy user base to finally enable the vision of a highly productive, informed and informative mobile sales force.
January 2012 - Tracking and responding to NHS change in a highly competitive Olympic year will be a test of endurance for medical sales professionals. In a light-hearted article, David Round, GM Cegedim Relationship Management UK, examines why winning a place amongst the medals will depend upon getting your preparation right.
January 2012 | Press coverage
January 2012 – Executives from Cegedim Relationship Management’s OPUS Health division discuss the positive impact copay programs have on patient adherence and outcomes.
January 2012 – Bill Buzzeo, Cegedim Relationship Management’s VP & GM of Global Compliance Solutions, discusses how preparing now for PPACA compliance will put you ahead come March 2013 … and will put you on the road to improving marketing performance today.
January 2012 – In this article about what lies ahead for pharma in 2012, Paul Kandle, Cegedim VP, discusses how copay programs can improve patient adherence and help produce a gain in public health outcomes.
January 2012 – The iPad serves to augment the relationship between reps and physicians. So says Neeraj Singhal, Cegedim VP, in this look at the pharma industry’s adoption of the iPad.
December 2011 – Neeraj Singhal, VP Product Management & Innovation for Cegedim Relationship Management, weighs in on this discussion about iPad adoption in the pharmaceutical industry.
December 2011 | Press coverage
December 2011 – Bill Buzzeo, VP & GM of Global Compliance Solutions for Cegedim Relationship Management, provides guidelines for developing and implementing FDA-required Risk Evaluation and Mitigation Strategies (REMS)
December 2011 - There has been a lot written about the industry’s apparent move to Key Account Management and its impact on call rates and targeting. David Round, UK General Manager, Cegedim Relationship Management, provides a welcome break from the rhetoric and concentrates instead on the facts.
December 2011 – Pedro Catalao, OneKey Director for Cegedim Relationship Management Portugal, discusses how the structure of Portugal’s National Health Service (NHS) has radically changed in recent years, creating an entirely new set of influencers and a pressing need for pharma to seek insights about them.
November 2011 – Cegedim Relationship Management co-hosted Pharm Exec's 2011 Emerging Pharma Leaders program, which included a gathering of some of the best minds in the industry under the age of 45, who hope to make a difference as the industry grapples with a future that is rift by uncertainty.
November 2011 | Press coverage
November 2011 – While sampling has been the traditional method of getting patients to try new therapies, the use of coupons or vouchers—often targeted directly to consumers rather than physicians—are on the increase. Paul Kandle, VP and GM of Opus Health, a division of Cegedim Relationship Management, discusses these programs.
November 2011 – Facing the challenge of multiple, overlapping models of healthcare delivery, pharmaceutical companies in Russia are beginning to tap into key opinion leaders (KOLs) and prescribing influence to drive effective market access strategies.
November 2011 - David Nalbant, Commercial and Marketing Solutions Director for Cegedim Relationship Management Austria, discusses market access in Austria – a country with unique go-to-market challenges.
November 2011 - Despite huge investments into CRM systems, some pharma companies still struggle to get all of their staff to embrace and fully interact with them. Cegedim’s UK GM, David Round, is cited in this article exploring why, and what the future holds for technology in the industry.
October 2011 – In this article about market access in Netherlands, Jack Turenhout, GM Cegedim Relationship Management Netherlands, examines shifts taking place in one of the highest rated health systems in the world.
October 2011 | Press coverage
October 2011 – Results of Cegedim Relationship Management’s 2011 Pharma Insights Survey shared by MM&M.
October 2011 – Jean-Claude Labrune, Chairman & CEO of Cegedim, is highlighted as an industry luminary in Pharmaceutical Executive’s special 30th anniversary issue.
October 2011 – Pharmaceutical Commerce reports on the findings revealed in Cegedim Relationship Management’s just-released Pharma Insights Survey Report.
October 2011 - Large pharma have begun to take a more de-risked approach to M&A transactions because of the increased complexity of both the regulatory and reimbursement environment.
October 2011 – Industry insights from Angela Miccoli, Cegedim Relationship Management's President North America, are cited in this Biopharm Insight article on pharma's new de-risked approach to M&A transactions.
September 2011 – Those wanting to bring products into this troubled market must understand and manage the country’s rapid move from prescriber to payer
September 2011 | Press coverage
September 2011 - In the past 4 years, the demands of the health service have changed dramatically, creating a wide range of new influencers at national and regional level that pharmaceutical companies must consider.
August 2011 – Cegedim VP of Global Compliance, Bill Buzzeo, is cited in this article about industry readiness to collect, aggregate, cleanse and disclose data about regulated financial transactions with doctors and hospitals.
August 2011 | Press coverage
August 2011 – A report on the current state of the pharmaceutical market in Russia by Lucia Railean, General Manager of Cegedim Relationship Management Russia.
August 2011 – Pharma has jumped on the bandwagon, but can the new device live up to the hype?
July 2011 – Neeraj Singhal, Vice President, Product Management and Innovation at Cegedim Relationship Management, and two other industry though leaders, discuss how the iPad affects pharmaceutical sales.
July 2011 | Press coverage
June 2011 – Cegedim is named as an industry leader in this IDC MarketScape report which provides a comprehensive evaluation of the leading sales force automation applications available for the pharmaceutical industry.
June 2011 | Press coverage
June 2011 – Cegedim’s Neeraj Singhal is quoted in this article about the industry’s pronounced fascination with Apple's iPad and the focus on mobility and data access in sales-IT efforts.
June 2011 – PharmaForum looks at the results of Cegedim Relationship Management’s 2011 Market Access in Europe Survey, and compares them with those of 2010.
May 2011 – In this article about cloud computing and the pharma industry, Neeraj Singhal, VP of Product Strategy & Innovation at Cegedim Relationship Management, provides his insights and concludes that “cloud computing is here to stay.”
May 2011 | Press coverage
May 2011 – Marc Migliorini, Cegedim’s Senior Marketing Director, joins other industry thought leaders in roundtable discussion about the thorny issues of patient adherence, compliance and persistence.
May 2011 - Cegedim’s VP of Support Services, Cindy Otterman, is included in this prestigious list of high-potential women from the life sciences industry who are significantly contributing to their organizations.
May 2011 – Comments on SFE trends from Cegedim Relationship Management’s VP of Marketing & Communications are included in this video recorded by Pharma Forum at eyeforpharma’s SFE Europe 2011 Conference in Düsseldorf, Germany.
April 2011 - How do pharmaceutical companies distinguish their brands and influence adoption by prescribers in the new healthcare environment? Industry experts, including Cegedim’s Mark Calabrese, VP & GM of Marketing Solutions, detail their strategies.
April 2011 | Press coverage
April 2011 – Despite significant investment from pharma, mobile technology hasn’t yet become the great enabler. But David Round, General Manager, Cegedim Relationship Management, explains why the arrival of new technologies combined with a technically savvy user base may finally realise the objectives of a highly productive, informed and informative mobile sales force.
March 2011 – Regulation is here to stay. Intended to maintain high ethical standards across the industry, regulation bolsters the industry by protecting against bribery and corruption. But even one high-profile breach of compliance can mar the industry as a whole.
March 2011 | Press coverage
February 2011 – This IDC Health Insights report, which discusses the current state of aggregate spend compliance, names Cegedim Relationship Management as the global market share leader in the space.
February 2011 | Press coverage
February 2011 – As pharmaceutical representatives increasingly make the Apple iPad their tablet of choice, developers are meeting their needs with a range of useful sales apps.
February 2011 – Changes in the field of oncology in the last twenty years have led to complex networks between physicians. To understand these networks Cegedim has produced Physician Connect Oncology, a nominative database profiling physicians and their networks.
January 2011 – Stefan Janssens, Cegedim Relationship Management President EMEA, answers the question: Can a market access strategy developed to support the demands of the European market really be successful in the Asia Pacific region?
January 2011 | Press coverage
January 2011 – Neeraj Singhal, VP Corporate Strategy & Business Innovation, participates in PharmaVOICE’s discussion on a customer-centric approach to sales.
January 2011 – PM360 interviews Angela Miccoli, President Americas of Cegedim Relationship Management, on how her company is addressing the Life Sciences industry’s current trends and challenges.
December 2010 - The onset of draconian anti-bribery legislation is forcing pharma companies to review their compliance policies and procedures. The global crackdown on “white collar crime” presents one of the biggest challenges to the life sciences sector. Pf explores a new survey of compliance in Europe. Is your company doing enough?
December 2010 | Press coverage
December 2010 - Making sense of the promotional spend and anti-corruption compliance burden is emerging as a key strategic issue for pharma—not just in the US but in the global market space as well, where regulatory safeguards are still porous.
November 2010 - In a roundtable discussion, pharma leaders, including Angela Miccoli, President Americas of Cegedim Relationship Management, consider the role of technology and information in shaping success for the future.
November 2010 | Press coverage
November 2010 – Pharmas aren’t merely downsizing reps, they’re rethinking the detail and installing specialized sales forces, breaking them up into regions and making outcomes king.
October 31, 2010 - The seemingly routine process of identifying and locating prescribing physicians is becoming a critical industry function.
October 2010 | Press coverage
October 13, 2010 - Stefan Janssens of Cegedim Relationship Management talks to Oncology consultant Alain Herrera about the most effective ways to identify and use key opinion leaders (KOLs) in today’s pharma landscape.
October 12, 2010 - Growing numbers of Americans with health insurance are walking away from their prescriptions at the pharmacy counter, the latest indication that efforts to contain costs may be curbing health-care consumption..
October, 2010Pharma is Taking its Byte of the Apple: Sales reps have been using mobile CRM applications on their smart phones and laptops for years, but the larger screen and “wow” factor of the iPad may bring additional benefits and functions to bear.Cegedim Relationship Management Streamlines Tracking, Reporting Capabilities: Today’s life-sciences companies need a solution that can automate the management of the massive amount of data required by the growing array of federal and state disclosure laws.
October, 2010 - Biopharmaceutical companies across Europe are facing an increasingly challenging marketplace — from the world economic climate to the growing prescribing influence exerted by health services and the diminishing domain of traditional prescribers.
September 30, 2010 - Due to an increasing number of hospital chains in India, biotech companies may be required to significantly revive their sales approaches in a market dominated by generic products, experts said.
September 2010 | Press coverage
August 25, 2010 - Facing a raft of emerging global legislation and increased regulation enforcement, life sciences companies need to put in place adequate measures to prevent charges of corruption and bribery, says Stefan Janssens, President, EMEA for Cegedim Relationship Management.
August 2010 | Press coverage
June, 2010 - Market access has for some years been one of pharma’s most widely used buzzphrases. But now it is one of its highest priorities. New data shows the industry knows it can no longer pay lip service to the notion of market access. It can, and must, do better.
June 2010 | Press coverage
May 12, 2010 - While many states already require aggregate spend reporting, the Physician Payments Sunshine Act takes it a step further, requiring drug companies to disclose aggregate spend at a federal level.
May 2010 | Press coverage
April 20, 2010 - Coupons give discounts on frozen meals, toothpaste, breakfast cereals and household cleaners. And increasingly, consumers are turning to coupons for their prescription medications, too.
April 2010 | Press coverage
Jan 30, 2010 - It's been said that CRM systems are only as good as the data that resides in them — and incorrect data can be more costly to a company than no data at all.
January 2010 | Press coverage
The origin of innovation may be shrouded in mystery, but a subset of the 2009 Emerging Pharma Leaders recently met with Pharmaceutical Executive publisher Jay Berfas to shed some light on the future of innovation in biopharma’s business models.
During the last few years, a shift has occurred within sales organizations in global pharmaceutical companies.